Longitudinal Single Cell Atlas Identifies Type I Interferon Response as an Early Transient Prognostic Signature of COVID-19 Severity
<p>The clinical spectrum of COVID-19 ranges from asymptomatic or mildly symptomatic illness to pneumonia, critical illness and death. Molecular markers early in the disease course (Days 1-8) that identify patients at high risk for progression are scarce, due to the paucity of relevant longitudinal studies. We performed longitudinal single cell RNA-seq on 286 peripheral blood samples from 108 age- and gender-matched COVID-19 patients, 73 of which had at least one early sample. By examining discrete cell subtypes as well as continuous single cell states, we identified upregulation of genes related to type I interferon (IFN) signaling as the predominant cellular prognostic signature of future disease severity. Type I IFN signaling was dynamic and complex, spiking early in Progressors and then receding to the level of Non-Progressors at the very next sampling. Across the entire cohort, expression of type I IFN signaling genes dropped steadily, falling to asymptomatic levels by Day 14 regardless of severity. Moreover, in severe and critical cases, IFN signaling was deficient during Days 5-8, potentially due to upregulation of <em>SOCS3</em> and other negative regulators. In summary, we have identified an early expression signature that may predict COVID-19 severity, as well as potential mechanisms underlying the dysfunctional host immune response in severe disease.</p>
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 4
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 4
- Engagement
- 0
Dataset details
- Repository
- zenodo
- Published
- September 22, 2021
- License
- cc-by-4.0
- DOI
- 10.5281/zenodo.5153527
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.